+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Telbivudine"

Hepatitis B Virus (HBV) Global Market Report 2024 - Product Thumbnail Image

Hepatitis B Virus (HBV) Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Telbivudine is an antiviral drug used to treat chronic hepatitis B virus (HBV) infection. It is a thymidine nucleoside analogue, which works by blocking the activity of the virus in the body. Telbivudine is usually prescribed in combination with other antiviral medications, such as pegylated interferon or entecavir. It is available in tablet form and is taken orally. Telbivudine is used to reduce the amount of HBV in the body and to reduce the risk of liver damage caused by the virus. It is also used to reduce the risk of HBV-related complications, such as cirrhosis and liver cancer. Telbivudine is not a cure for HBV infection, but it can help to reduce the amount of virus in the body and reduce the risk of complications. Telbivudine is a widely used drug in the infectious diseases drugs market. It is used to treat chronic HBV infection and is an important part of the treatment regimen for this condition. Some companies in the telbivudine market include Novartis, Merck, and GlaxoSmithKline. Show Less Read more